Pfizer-BioNTech to seek Covid-19 vaccine approval ‘within days’ as trial shows 95 percent efficacy – NBC News

LONDON A leading coronavirus vaccine candidate developed by Pfizer and BioNTech will be submitted for regulatory approval “within days,” the companies announced Wednesday, after their final analysis … [read more]

Leave a Reply

Your email address will not be published. Required fields are marked *